Artificial intelligence news.
Straight from the original announcements.

SAMILBIO Plans 2026 Launch for NpillAI Health Food Platform

November 11, 2026, 02:00By the AI News Bites Editorial TeamSource: PR Newswire

SAMILBIO is preparing to launch NpillAI within 2026, a health functional food platform that combines 24-hour AI chat consultation with direct pharmacist review. The service will use health checkup and medication data to provide nutrition management information and connect recommendations with purchase and delivery.

Key points
  • NpillAI is being prepared for launch within 2026.
  • The service combines AI chat consultation with pharmacist review.
  • Recommendations will reference health checkup and medication data.
  • SAMILBIO plans to connect recommendations with purchase and delivery.
  • Kiosk integration development has been completed.

AI consultation followed by pharmacist review

NpillAI is designed for people who are interested in health functional foods but find it difficult to determine which products fit their circumstances. SAMILBIO says the service will allow users to access nutrition management information at any time through an AI chat consultation.

The platform will reference users' health checkup and medication data when providing information. Its recommendations will then be reviewed directly by a pharmacist, adding a human review step to the AI-based information process.

According to SAMILBIO, this approach is intended to help consumers who have busy schedules, find it difficult to visit a pharmacy, or need help deciding which health functional foods to choose. The company says NpillAI is in the final stage of development and is being prepared for launch in 2026.

A single path from consultation to delivery

SAMILBIO is building NpillAI around the full process from information gathering to product selection, purchase, and delivery. After users receive product recommendations, the company plans to connect them with purchasing and delivery options.

The company says this could reduce the need to search for and buy products separately after a consultation. Its stated aim is to make it easier for consultation results to lead to actual product choices, rather than leaving users to manage the next steps on their own.

SAMILBIO describes the gap between interest in nutrition management and selecting a suitable product as the problem NpillAI is intended to address. The company plans to refine the service after launch by reviewing how users begin consultations, assess information, and select products.

Kiosk integration is ready for further deployment

SAMILBIO has also completed development of kiosk integration connected to the online service. The company is preparing to make NpillAI available both online and on-site, although it has not specified installation locations or operating methods in the announcement.

The next step is to apply the completed integration in real-world usage environments. SAMILBIO says it will prioritize the service launch and preparations for on-site deployment, then continue improving issues identified through actual use.

The company will also refine the pharmacist review process so it operates smoothly within the service and continue preparing the kiosk for real-world environments. SAMILBIO, which opened for business in April 2023, says launching NpillAI within the year is a priority. “NpillAI focuses on reducing inconvenience for people who are interested in health functional foods but find it hard to determine which products they need, or who struggle to find time for a consultation,” SAMILBIO said.

Related news

ScreenPoint Medical Names Parul Sharma Chief Commercial Officer
BusinessNovember 16, 2026, 10:00

ScreenPoint Medical Names Parul Sharma Chief Commercial Officer

ScreenPoint Medical has appointed Parul Sharma as its chief commercial officer, adding her to the company's Management Team. She will lead the global go-to-market…

SAS and Posit join forces on governed AI for life sciences
BusinessNovember 16, 2026, 09:00

SAS and Posit join forces on governed AI for life sciences

SAS and Posit have partnered to help life science organizations combine SAS and open source technologies, initially focusing on clinical development. The integration is…

SAS and Posit Partner on Governed AI for Life Sciences
BusinessNovember 16, 2026, 09:00

SAS and Posit Partner on Governed AI for Life Sciences

SAS and Posit PBC have formed a partnership to give life sciences organizations more flexibility in using SAS and open-source technologies, initially for clinical…